Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BM-MSC for Intervertebral Disc Degeneration (DREAM)
NCT05066334Phase 2Recruiting
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Mar 2021
- Primary completion
- Oct 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone-marrow mesenchymal stem cells in intervertebral disc degeneration (DDD), chronic low back pain (CLBP), sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Started Mar 2021; status: recruiting.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
intervertebral disc degeneration (DDD)chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT05066334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066334.